甲状腺眼病患者临床活动度评分(CAS)的观察者间变异性评估
本研究为前瞻性信度分析,由6名经验丰富的评估者对9例具有不同临床特征的甲状腺眼病患者在同一天进行临床活动度评分(CAS),采用Krippendorff alpha分析观察者间一致性。结果显示CAS总分的alpha为0.532(95%CI=0.199-0.665),各单项成分的alpha在0.171至0.671之间,提示CAS总分及多数成分的观察者间一致性不可靠。
要点
- CAS总分的Krippendorff alpha为0.532(95%CI=0.199-0.665),观察者间一致性不可靠。
- 单项成分alpha从眼睑发红的0.171(CI=0.000-0.334)到自发性疼痛的0.671(CI=0.294-1.000)。
- 以CAS≥3分作为适合抗炎治疗的判断时,评估者间是否给治疗的alpha为0.332(95%CI=0.0011-0.5862)。
核心结论
- 研究显示CAS总分及多数单项成分的观察者间变异性不可靠,提示需要改进CAS的表现或寻找其他评估疾病活动度的方法。
研究设计与样本
- 前瞻性信度分析;9例具有不同临床特征的甲状腺眼病患者由6名经验丰富的评估者在同一天完成评估,采用Krippendorff alpha分析观察者间一致性。
主要发现
- CAS总分的Krippendorff alpha为0.532(95%CI=0.199-0.665)。
- 单项成分的alpha值在0.171至0.671之间,其中眼睑发红为0.171(CI=0.000-0.334),自发性疼痛为0.671(CI=0.294-1.000)。
- 假设CAS值≥3分意味着患者适合抗炎治疗,评估者间关于是否应给予治疗的Krippendorff alpha为0.332(95%CI=0.0011-0.5862)。
关键数值与推荐
- CAS总分Krippendorff alpha=0.532(95%CI=0.199-0.665)。
- 眼睑发红alpha=0.171(CI=0.000-0.334),自发性疼痛alpha=0.671(CI=0.294-1.000)。
- 以CAS≥3分作为适合抗炎治疗的判断时,是否给予治疗的评估者间alpha=0.332(95%CI=0.0011-0.5862)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Thyroid eye disease (TED) can be difficult to manage. The range of available treatments is expanding rapidly; however, cost is a concern and some patients do not respond. The Clinical Activity Score (CAS) was devised as a measure of disease activity and a potential predictor of response to anti-inflammatory treatment. Despite the widespread use of the CAS, inter-observer variability has not been investigated. The aim of the study was to determine the inter-observer variability of the CAS in patients with TED. DESIGN: Prospective reliability analysis. METHODS: Nine patients with a spectrum of clinical features of TED were assessed by 6 experienced observers on the same day. Agreement among the observers was analyzed using the Krippendorff alpha. RESULTS: The Krippendorff alpha for the total CAS was 0.532 (95% CI = 0.199-0.665), whereas alpha values for the individual components of the CAS varied between 0.171 (CI = 0.000-0.334) for lid redness and 0.671 (CI = 0.294-1.000) for spontaneous pain. Assuming that a CAS value ≥3 implies suitability of the patient for anti-inflammatory treatment, the calculated Krippendorff alpha for agreement among assessors on whether treatment should be given or not given was 0.332 (95% CI = 0.0011-0.5862). CONCLUSIONS: This study has shown unreliable inter-observer variability in total CAS and most individual CAS components, thus highlighting the need for improving the performance of the CAS or seeking other methods to assess activity.
引用
- Perros P, Žarković M, Pearce SH, et al. Inter-observer Variability of Clinical Activity Score: Assessments in Patients With Thyroid Eye Disease. Am J Ophthalmol. 2023. PMID: 37028695. doi:10.1016/j.ajo.2023.03.027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。